Cancer patients in sepsis trial: can we use fewer strong antibiotics?
NCT ID NCT03683329
Summary
This study tested if it's safe to reduce the use of powerful, broad-spectrum antibiotics in cancer patients with life-threatening sepsis. Researchers compared two strategies: continuing the initial strong antibiotics versus switching to more targeted ones once the specific infection was identified. The main goal was to see if the 'de-escalation' approach was just as good at preventing hospital deaths, while also aiming to reduce the risk of creating drug-resistant superbugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL CARE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Paoli Calmettes
Marseille, 13273, France
Conditions
Explore the condition pages connected to this study.